Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION

Mes dernières consult.
Top consultations
20
SynthèseGraphiquesActualitésAgendaSociétéFinancesFondsCommunauté 
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert552015President, Secretary, Treasurer & Director
William Monteith582009Executive Vice President-Technical Operations
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Secteur
Santé
Recherche pharmaceutique et médicale
 Recherche biotechnologique et médicale
  Recherche biotechnologique et médicale
   Recherche biotechnologique et médicale - NCA
Publicité
Secteur Recherche biotechnologique et médicale - NCA
Var. 1janvCapitalisation (M$)
DENDREON CORPORATION-55.48%0
INCYTE CORPORATION40.35%28 684
QUINTILES IMS HOLDINGS..2.46%18 383
LONZA GROUP AG4.76%10 627
CELLTRION, INC.--.--%9 785
SEATTLE GENETICS, INC.17.40%8 827
ALKERMES PLC3.20%8 750
QIAGEN NV-1.47%6 618
UNITED THERAPEUTICS CO..-3.59%6 217
IONIS PHARMACEUTICALS ..-20.05%4 732
ALNYLAM PHARMACEUTICAL..44.79%4 665
ACADIA PHARMACEUTICALS..21.39%4 250
ICON PLC3.43%4 241
CHARLES RIVER LABORATO..15.66%4 175
BIO-TECHNE CORP-0.53%3 817
GALAPAGOS22.50%3 734
PRA HEALTH SCIENCES IN..6.53%3 620
NEKTAR THERAPEUTICS77.91%3 358
PAREXEL INTERNATIONAL ..-6.80%3 121
BB BIOTECH AG1.45%3 057
IRONWOOD PHARMACEUTICA..10.86%2 506
Secteur Recherche biotechnologique et médicale - NCA
Dendreon Corporation : Connexions
CompuCyte Corp.
Seaside Therapeutics, Inc.
SIONEX Corp.
Coordonnées société
Dendreon Corp.
1208 Eastlake Avenue East
Seattle, WA 98102

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
© 2017 People , Fundamentals and Ownership